These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21805730)

  • 1. [Malignant transformation of hepatocytes and the specific biomarkers for hepatocellular carcinoma].
    Yao M; Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):244-6. PubMed ID: 21805730
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: histological, histochemical and microbiochemical characterization of the novel variant.
    Callea F; Giovannoni I; Stefanelli M; Villanacci V; Lorini G; Francalanci P
    Histopathology; 2012 May; 60(6):1010-2. PubMed ID: 22321151
    [No Abstract]   [Full Text] [Related]  

  • 3. Irregular regeneration of hepatocytes and development of hepatocellular carcinoma in primary biliary cirrhosis.
    Miyakawa H; Fujikawa H; Kikuchi K; Kitazawa E; Kawashima Y
    Am J Gastroenterol; 2002 Feb; 97(2):488. PubMed ID: 11866295
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relationship between abnormal expression of heat shock protein 90 and malignant transformation of hepatocytes].
    Su XQ; Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):314-7. PubMed ID: 16635315
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dynamic alterations of VEGF and intervention of its expression on effect of hepatocyte malignant transformation].
    Yao DF; Qiu LW; Wu W; Yao NH; Li SS; Bian YZ
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(42):3014-8. PubMed ID: 21211317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Specific biomarkers for the diagnosis and prognosis of hepatocellular carcinoma].
    Wang HY
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):241-3. PubMed ID: 21805729
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic utility of GLUT1 in the differential diagnosis of liver carcinomas.
    Roh MS; Jeong JS; Kim YH; Kim MC; Hong SH
    Hepatogastroenterology; 2004; 51(59):1315-8. PubMed ID: 15362741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New epidemiological data on liver oncogenesis.
    Kountouras J; Lygidakis NJ
    Hepatogastroenterology; 2000; 47(33):855-61. PubMed ID: 10919047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of histological biopsy diagnosis of hepatocellular carcinoma by genomic biomarkers?
    Lamerz R
    Gut; 2011 Jul; 60(7):881-2. PubMed ID: 21436226
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
    Morrison C; Marsh W; Frankel WL
    Mod Pathol; 2002 Dec; 15(12):1279-87. PubMed ID: 12481008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma metastatic to the orbit: a case report.
    Oida Y; Ohtani Y; Dowaki S; Tobita K; Mukai M; Abe Y; Nakamura M; Imaizumi T; Makuuchi H
    Tokai J Exp Clin Med; 2006 Apr; 31(1):7-10. PubMed ID: 21302214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of somatostatin analogs in the management of hepatocellular carcinoma.
    D'Agostino L; Manguso F; Pivonello R; Colao A
    J Endocrinol Invest; 2003; 26(8 Suppl):131-3. PubMed ID: 15233229
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary liver tumors: origin and target therapy.
    Papoulas M; Theocharis S
    Expert Opin Ther Targets; 2009 Aug; 13(8):957-65. PubMed ID: 19606929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty change in human hepatocellular carcinoma cell lines derived from patients with antibodies to hepatitis C virus.
    Seki S; Kitada T; Kawada N; Kadoya H; Sakaguchi H; Nakatani K; Satake K
    Hepatogastroenterology; 2002; 49(44):340-4. PubMed ID: 11995446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liver cell dysplasia: a crosstalk between the clinician and the pathologist].
    Dumortier J; Scoazec JY
    Ann Pathol; 2001 Apr; 21(2):117-20. PubMed ID: 11373580
    [No Abstract]   [Full Text] [Related]  

  • 16. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clustered ground-glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery.
    Tsai HW; Lin YJ; Lin PW; Wu HC; Hsu KH; Yen CJ; Chan SH; Huang W; Su IJ
    Cancer; 2011 Jul; 117(13):2951-60. PubMed ID: 21692054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver cancer stem cells: implications for a new therapeutic target.
    Lee TK; Castilho A; Ma S; Ng IO
    Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of hepatocellular carcinoma: role of tumor markers and liver biopsy.
    Gonzalez SA; Keeffe EB
    Clin Liver Dis; 2011 May; 15(2):297-306, vii-x. PubMed ID: 21689614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal transition in the liver.
    Firrincieli D; Boissan M; Chignard N
    Gastroenterol Clin Biol; 2010 Oct; 34(10):523-8. PubMed ID: 20615641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.